+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
NDDS in Cancer Therapy Market by Product Type (Dendrimers, Exosomes, Lipid Nanocarriers), Drug Type (Gene Therapy Agents, Monoclonal Antibodies, Oligonucleotide Drugs), Application, Technology Platform - Global Forecast 2025-2030- Product Image
NDDS in Cancer Therapy Market by Product Type (Dendrimers, Exosomes, Lipid Nanocarriers), Drug Type (Gene Therapy Agents, Monoclonal Antibodies, Oligonucleotide Drugs), Application, Technology Platform - Global Forecast 2025-2030- Product Image
Sale

NDDS in Cancer Therapy Market by Product Type (Dendrimers, Exosomes, Lipid Nanocarriers), Drug Type (Gene Therapy Agents, Monoclonal Antibodies, Oligonucleotide Drugs), Application, Technology Platform - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 192 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 5888824
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The NDDS in Cancer Therapy Market is entering a new phase marked by rapidly advancing nanotechnology, shifting regulatory landscapes, and rising demand for patient-centric oncology solutions. For senior executives, this report distills emerging trends and actionable insights to support strategic planning and capital allocation in a highly competitive arena.

Market Snapshot: NDDS in Cancer Therapy Market

In 2024, the NDDS in Cancer Therapy Market reached USD 11.75 billion, expanding to USD 13.35 billion in 2025. This robust momentum is forecast to continue with a CAGR of 13.38%, paving the way to a projected USD 24.98 billion by 2030. These growth trends reflect accelerated adoption of nanomedicine, expanding biotechnology investments, and the increasing need for precision-based oncology therapeutics worldwide.

Scope & Segmentation of the NDDS in Cancer Therapy Market

This comprehensive analysis offers a structured view across product, drug, application, and technology segments, as well as detailed regional coverage.

  • Product Type: Dendrimers, Exosomes, Lipid Nanocarriers, Liposomes, Metallic Nanoparticles, Micelles, Nanoemulsions, Polymeric Nanoparticles
  • Drug Type: Gene Therapy Agents, Monoclonal Antibodies, Oligonucleotide Drugs, SiRNA, Small-Molecule Chemotherapeutics
  • Application: Chemotherapy, Immunotherapy, Photodynamic Therapy, Radiotherapy, Targeted Therapy
  • Technology Platform: Implantable Depot Systems, Injectable Suspensions, Microneedle Systems, Active Targeting (Ligand Targeted, Receptor Mediated), Passive Targeting
  • Geographical Coverage: Americas (United States—California, Texas, New York, Florida, Illinois, Pennsylvania, Ohio; Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (United Kingdom, Germany, France, Russia, Italy, Spain, United Arab Emirates, Saudi Arabia, South Africa, Denmark, Netherlands, Qatar, Finland, Sweden, Nigeria, Egypt, Turkey, Israel, Norway, Poland, Switzerland), Asia-Pacific (China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan)
  • Key Companies Assessed: Johnson & Johnson, F. Hoffmann-La Roche Ltd, Pfizer Inc., Novartis AG, AstraZeneca PLC, Merck & Co., Inc., Bristol-Myers Squibb Company, Sanofi S.A., Amgen Inc., AbbVie Inc.

Key Takeaways: Strategic Insights for Decision-Makers

  • Next-generation nanocarriers are significantly advancing oncology drug delivery by improving safety profiles and reducing off-target effects, providing new opportunities for competitive differentiation.
  • Personalized medicine initiatives are driving investment in adaptable drug delivery systems, enabling tailored therapeutic solutions and shifting expectations for efficacy and patient outcomes.
  • Collaborations between biopharma, academia, and technology specialists are accelerating clinical translation and the scale-up of novel platforms for targeted drug delivery in cancer treatment.
  • Manufacturing advances, such as modular units and continuous flow reactors, are supporting scalable production while maintaining quality and mitigating potential bottlenecks.
  • The integration of digital health tools and real-time monitoring is embedded in development strategies, optimizing patient stratification and outcome-based reimbursement approaches.
  • Regional dynamics are creating distinct adoption paths: the Americas leverage R&D and payer readiness, Europe and the Middle East emphasize regulatory harmonization, while Asia-Pacific delivers scale and innovation in manufacturing.

Tariff Impact: Assessing U.S. Policy Shifts on Supply Chain Strategy

Forthcoming 2025 U.S. tariffs are expected to impact the NDDS in Cancer Therapy Market by increasing costs for specialized inputs, such as advanced polymers and nanoparticle precursors. Industry participants may need to pivot toward reshoring, build supplier redundancies, or streamline procurement to offset material cost rises. These shifts are likely to influence sourcing strategies, project lead times, and long-term research budget allocations across the value chain.

Methodology & Data Sources

This analysis relies on a dual approach: in-depth secondary research—including journals, patents, and regulatory filings—combined with primary interviews involving oncologists, scientists, engineers, and commercial leaders. Quantitative findings were validated using triangulation from multiple independent sources to support thematic consistency and robust benchmarking.

Why This Report Matters

  • Offers actionable intelligence to guide R&D prioritization and portfolio development in the context of evolving regulatory and reimbursement environments.
  • Supports informed investment decisions by mapping the impact of technology innovation, supply chain pressures, and market adoption patterns on oncology therapies.
  • Enables competitive positioning by highlighting market trajectories, partnership dynamics, and opportunities for international expansion.

Conclusion: Future Trajectory of Nanotechnology-Based Delivery in Oncology

The NDDS in Cancer Therapy Market is redefining treatment standards as stakeholders invest in strategic partnerships, supply chain agility, and advanced manufacturing. Organizations that unite technological innovation with adaptive execution will unlock substantial value for next-generation oncology solutions.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Clinical translation of tumor microenvironment responsive nanoparticle platforms enhancing selective drug release
5.2. Development of multifunctional lipid nanoparticle systems co-delivering siRNA and chemotherapeutics for resistant tumors
5.3. Engineering of biomimetic exosome-inspired nanocarriers for targeted immunomodulatory cargo delivery
5.4. Integration of real-time imaging modalities within theranostic nanoparticle drug delivery systems for monitoring treatment
5.5. Advancement in stimuli responsive polymeric micelles exploiting tumor pH and enzyme triggers for on-demand drug release
5.6. Adoption of personalized nanoparticle vaccines combining neoantigen peptides and adjuvants for cancer immunotherapy
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. NDDS in Cancer Therapy Market, by Product Type
8.1. Introduction
8.2. Dendrimers
8.3. Exosomes
8.4. Lipid Nanocarriers
8.5. Liposomes
8.6. Metallic Nanoparticles
8.7. Micelles
8.8. Nanoemulsions
8.9. Polymeric Nanoparticles
9. NDDS in Cancer Therapy Market, by Drug Type
9.1. Introduction
9.2. Gene Therapy Agents
9.3. Monoclonal Antibodies
9.4. Oligonucleotide Drugs
9.5. SiRNA
9.6. Small-Molecule Chemotherapeutics
10. NDDS in Cancer Therapy Market, by Application
10.1. Introduction
10.2. Chemotherapy
10.3. Immunotherapy
10.4. Photodynamic Therapy
10.5. Radiotherapy
10.6. Targeted Therapy
11. NDDS in Cancer Therapy Market, by Technology Platform
11.1. Introduction
11.2. Implantable Depot Systems
11.3. Injectable Suspensions
11.4. Microneedle Systems
11.5. Nanotechnology
11.5.1. Active Targeting
11.5.1.1. Ligand Targeted
11.5.1.2. Receptor Mediated
11.5.2. Passive Targeting
12. Americas NDDS in Cancer Therapy Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa NDDS in Cancer Therapy Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific NDDS in Cancer Therapy Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Johnson & Johnson
15.3.2. F. Hoffmann-La Roche Ltd
15.3.3. Pfizer Inc.
15.3.4. Novartis AG
15.3.5. AstraZeneca PLC
15.3.6. Merck & Co., Inc.
15.3.7. Bristol-Myers Squibb Company
15.3.8. Sanofi S.A.
15.3.9. Amgen Inc.
15.3.10. AbbVie Inc.
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. NDDS IN CANCER THERAPY MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL NDDS IN CANCER THERAPY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL NDDS IN CANCER THERAPY MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL NDDS IN CANCER THERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL NDDS IN CANCER THERAPY MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL NDDS IN CANCER THERAPY MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL NDDS IN CANCER THERAPY MARKET SIZE, BY DRUG TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL NDDS IN CANCER THERAPY MARKET SIZE, BY DRUG TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL NDDS IN CANCER THERAPY MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL NDDS IN CANCER THERAPY MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL NDDS IN CANCER THERAPY MARKET SIZE, BY TECHNOLOGY PLATFORM, 2024 VS 2030 (%)
FIGURE 12. GLOBAL NDDS IN CANCER THERAPY MARKET SIZE, BY TECHNOLOGY PLATFORM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS NDDS IN CANCER THERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS NDDS IN CANCER THERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES NDDS IN CANCER THERAPY MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES NDDS IN CANCER THERAPY MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA NDDS IN CANCER THERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA NDDS IN CANCER THERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC NDDS IN CANCER THERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC NDDS IN CANCER THERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. NDDS IN CANCER THERAPY MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. NDDS IN CANCER THERAPY MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 23. NDDS IN CANCER THERAPY MARKET: RESEARCHAI
FIGURE 24. NDDS IN CANCER THERAPY MARKET: RESEARCHSTATISTICS
FIGURE 25. NDDS IN CANCER THERAPY MARKET: RESEARCHCONTACTS
FIGURE 26. NDDS IN CANCER THERAPY MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. NDDS IN CANCER THERAPY MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL NDDS IN CANCER THERAPY MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL NDDS IN CANCER THERAPY MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL NDDS IN CANCER THERAPY MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL NDDS IN CANCER THERAPY MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL NDDS IN CANCER THERAPY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL NDDS IN CANCER THERAPY MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL NDDS IN CANCER THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL NDDS IN CANCER THERAPY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL NDDS IN CANCER THERAPY MARKET SIZE, BY DENDRIMERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL NDDS IN CANCER THERAPY MARKET SIZE, BY DENDRIMERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL NDDS IN CANCER THERAPY MARKET SIZE, BY EXOSOMES, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL NDDS IN CANCER THERAPY MARKET SIZE, BY EXOSOMES, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL NDDS IN CANCER THERAPY MARKET SIZE, BY LIPID NANOCARRIERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL NDDS IN CANCER THERAPY MARKET SIZE, BY LIPID NANOCARRIERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL NDDS IN CANCER THERAPY MARKET SIZE, BY LIPOSOMES, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL NDDS IN CANCER THERAPY MARKET SIZE, BY LIPOSOMES, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL NDDS IN CANCER THERAPY MARKET SIZE, BY METALLIC NANOPARTICLES, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL NDDS IN CANCER THERAPY MARKET SIZE, BY METALLIC NANOPARTICLES, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL NDDS IN CANCER THERAPY MARKET SIZE, BY MICELLES, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL NDDS IN CANCER THERAPY MARKET SIZE, BY MICELLES, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL NDDS IN CANCER THERAPY MARKET SIZE, BY NANOEMULSIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL NDDS IN CANCER THERAPY MARKET SIZE, BY NANOEMULSIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL NDDS IN CANCER THERAPY MARKET SIZE, BY POLYMERIC NANOPARTICLES, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL NDDS IN CANCER THERAPY MARKET SIZE, BY POLYMERIC NANOPARTICLES, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL NDDS IN CANCER THERAPY MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL NDDS IN CANCER THERAPY MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL NDDS IN CANCER THERAPY MARKET SIZE, BY GENE THERAPY AGENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL NDDS IN CANCER THERAPY MARKET SIZE, BY GENE THERAPY AGENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL NDDS IN CANCER THERAPY MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL NDDS IN CANCER THERAPY MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL NDDS IN CANCER THERAPY MARKET SIZE, BY OLIGONUCLEOTIDE DRUGS, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL NDDS IN CANCER THERAPY MARKET SIZE, BY OLIGONUCLEOTIDE DRUGS, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL NDDS IN CANCER THERAPY MARKET SIZE, BY SIRNA, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL NDDS IN CANCER THERAPY MARKET SIZE, BY SIRNA, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL NDDS IN CANCER THERAPY MARKET SIZE, BY SMALL-MOLECULE CHEMOTHERAPEUTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL NDDS IN CANCER THERAPY MARKET SIZE, BY SMALL-MOLECULE CHEMOTHERAPEUTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL NDDS IN CANCER THERAPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL NDDS IN CANCER THERAPY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL NDDS IN CANCER THERAPY MARKET SIZE, BY CHEMOTHERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL NDDS IN CANCER THERAPY MARKET SIZE, BY CHEMOTHERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL NDDS IN CANCER THERAPY MARKET SIZE, BY IMMUNOTHERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL NDDS IN CANCER THERAPY MARKET SIZE, BY IMMUNOTHERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL NDDS IN CANCER THERAPY MARKET SIZE, BY PHOTODYNAMIC THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL NDDS IN CANCER THERAPY MARKET SIZE, BY PHOTODYNAMIC THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL NDDS IN CANCER THERAPY MARKET SIZE, BY RADIOTHERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL NDDS IN CANCER THERAPY MARKET SIZE, BY RADIOTHERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL NDDS IN CANCER THERAPY MARKET SIZE, BY TARGETED THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL NDDS IN CANCER THERAPY MARKET SIZE, BY TARGETED THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL NDDS IN CANCER THERAPY MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL NDDS IN CANCER THERAPY MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL NDDS IN CANCER THERAPY MARKET SIZE, BY IMPLANTABLE DEPOT SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL NDDS IN CANCER THERAPY MARKET SIZE, BY IMPLANTABLE DEPOT SYSTEMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL NDDS IN CANCER THERAPY MARKET SIZE, BY INJECTABLE SUSPENSIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL NDDS IN CANCER THERAPY MARKET SIZE, BY INJECTABLE SUSPENSIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL NDDS IN CANCER THERAPY MARKET SIZE, BY MICRONEEDLE SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL NDDS IN CANCER THERAPY MARKET SIZE, BY MICRONEEDLE SYSTEMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL NDDS IN CANCER THERAPY MARKET SIZE, BY NANOTECHNOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL NDDS IN CANCER THERAPY MARKET SIZE, BY NANOTECHNOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL NDDS IN CANCER THERAPY MARKET SIZE, BY ACTIVE TARGETING, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL NDDS IN CANCER THERAPY MARKET SIZE, BY ACTIVE TARGETING, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL NDDS IN CANCER THERAPY MARKET SIZE, BY LIGAND TARGETED, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL NDDS IN CANCER THERAPY MARKET SIZE, BY LIGAND TARGETED, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL NDDS IN CANCER THERAPY MARKET SIZE, BY RECEPTOR MEDIATED, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL NDDS IN CANCER THERAPY MARKET SIZE, BY RECEPTOR MEDIATED, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL NDDS IN CANCER THERAPY MARKET SIZE, BY ACTIVE TARGETING, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL NDDS IN CANCER THERAPY MARKET SIZE, BY ACTIVE TARGETING, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL NDDS IN CANCER THERAPY MARKET SIZE, BY PASSIVE TARGETING, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL NDDS IN CANCER THERAPY MARKET SIZE, BY PASSIVE TARGETING, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL NDDS IN CANCER THERAPY MARKET SIZE, BY NANOTECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL NDDS IN CANCER THERAPY MARKET SIZE, BY NANOTECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 73. AMERICAS NDDS IN CANCER THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 74. AMERICAS NDDS IN CANCER THERAPY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 75. AMERICAS NDDS IN CANCER THERAPY MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 76. AMERICAS NDDS IN CANCER THERAPY MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 77. AMERICAS NDDS IN CANCER THERAPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 78. AMERICAS NDDS IN CANCER THERAPY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 79. AMERICAS NDDS IN CANCER THERAPY MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 80. AMERICAS NDDS IN CANCER THERAPY MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 81. AMERICAS NDDS IN CANCER THERAPY MARKET SIZE, BY NANOTECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 82. AMERICAS NDDS IN CANCER THERAPY MARKET SIZE, BY NANOTECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 83. AMERICAS NDDS IN CANCER THERAPY MARKET SIZE, BY ACTIVE TARGETING, 2018-2024 (USD MILLION)
TABLE 84. AMERICAS NDDS IN CANCER THERAPY MARKET SIZE, BY ACTIVE TARGETING, 2025-2030 (USD MILLION)
TABLE 85. AMERICAS NDDS IN CANCER THERAPY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 86. AMERICAS NDDS IN CANCER THERAPY MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 87. UNITED STATES NDDS IN CANCER THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 88. UNITED STATES NDDS IN CANCER THERAPY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 89. UNITED STATES NDDS IN CANCER THERAPY MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 90. UNITED STATES NDDS IN CANCER THERAPY MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 91. UNITED STATES NDDS IN CANCER THERAPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 92. UNITED STATES NDDS IN CANCER THERAPY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 93. UNITED STATES NDDS IN CANCER THERAPY MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 94. UNITED STATES NDDS IN CANCER THERAPY MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 95. UNITED STATES NDDS IN CANCER THERAPY MARKET SIZE, BY NANOTECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 96. UNITED STATES NDDS IN CANCER THERAPY MARKET SIZE, BY NANOTECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 97. UNITED STATES NDDS IN CANCER THERAPY MARKET SIZE, BY ACTIVE TARGETING, 2018-2024 (USD MILLION)
TABLE 98. UNITED STATES NDDS IN CANCER THERAPY MARKET SIZE, BY ACTIVE TARGETING, 2025-2030 (USD MILLION)
TABLE 99. UNITED STATES NDDS IN CANCER THERAPY MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 100. UNITED STATES NDDS IN CANCER THERAPY MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 101. CANADA NDDS IN CANCER THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 102. CANADA NDDS IN CANCER THERAPY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 103. CANADA NDDS IN CANCER THERAPY MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 104. CANADA NDDS IN CANCER THERAPY MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 105. CANADA NDDS IN CANCER THERAPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 106. CANADA NDDS IN CANCER THERAPY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 107. CANADA NDDS IN CANCER THERAPY MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 108. CANADA NDDS IN CANCER THERAPY MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 109. CANADA NDDS IN CANCER THERAPY MARKET SIZE, BY NANOTECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 110. CANADA NDDS IN CANCER THERAPY MARKET SIZE, BY NANOTECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 111. CANADA NDDS IN CANCER THERAPY MARKET SIZE, BY ACTIVE TARGETING, 2018-2024 (USD MILLION)
TABLE 112. CANADA NDDS IN CANCER THERAPY MARKET SIZE, BY ACTIVE TARGETING, 2025-2030 (USD MILLION)
TABLE 113. MEXICO NDDS IN CANCER THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 114. MEXICO NDDS IN CANCER THERAPY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 115. MEXICO NDDS IN CANCER THERAPY MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 116. MEXICO NDDS IN CANCER THERAPY MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 117. MEXICO NDDS IN CANCER THERAPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 118. MEXICO NDDS IN CANCER THERAPY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 119. MEXICO NDDS IN CANCER THERAPY MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 120. MEXICO NDDS IN CANCER THERAPY MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 121. MEXICO NDDS IN CANCER THERAPY MARKET SIZE, BY NANOTECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 122. MEXICO NDDS IN CANCER THERAPY MARKET SIZE, BY NANOTECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 123. MEXICO NDDS IN CANCER THERAPY MARKET SIZE, BY ACTIVE TARGETING, 2018-2024 (USD MILLION)
TABLE 124. MEXICO NDDS IN CANCER THERAPY MARKET SIZE, BY ACTIVE TARGETING, 2025-2030 (USD MILLION)
TABLE 125. BRAZIL NDDS IN CANCER THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 126. BRAZIL NDDS IN CANCER THERAPY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 127. BRAZIL NDDS IN CANCER THERAPY MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 128. BRAZIL NDDS IN CANCER THERAPY MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 129. BRAZIL NDDS IN CANCER THERAPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 130. BRAZIL NDDS IN CANCER THERAPY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 131. BRAZIL NDDS IN CANCER THERAPY MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 132. BRAZIL NDDS IN CANCER THERAPY MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 133. BRAZIL NDDS IN CANCER THERAPY MARKET SIZE, BY NANOTECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 134. BRAZIL NDDS IN CANCER THERAPY MARKET SIZE, BY NANOTECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 135. BRAZIL NDDS IN CANCER THERAPY MARKET SIZE, BY ACTIVE TARGETING, 2018-2024 (USD MILLION)
TABLE 136. BRAZIL NDDS IN CANCER THERAPY MARKET SIZE, BY ACTIVE TARGETING, 2025-2030 (USD MILLION)
TABLE 137. ARGENTINA NDDS IN CANCER THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 138. ARGENTINA NDDS IN CANCER THERAPY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 139. ARGENTINA NDDS IN CANCER THERAPY MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 140. ARGENTINA NDDS IN CANCER THERAPY MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 141. ARGENTINA NDDS IN CANCER THERAPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 142. ARGENTINA NDDS IN CANCER THERAPY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 143. ARGENTINA NDDS IN CANCER THERAPY MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 144. ARGENTINA NDDS IN CANCER THERAPY MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 145. ARGENTINA NDDS IN CANCER THERAPY MARKET SIZE, BY NANOTECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 146. ARGENTINA NDDS IN CANCER THERAPY MARKET SIZE, BY NANOTECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 147. ARGENTINA NDDS IN CANCER THERAPY MARKET SIZE, BY ACTIVE TARGETING, 2018-2024 (USD MILLION)
TABLE 148. ARGENTINA NDDS IN CANCER THERAPY MARKET SIZE, BY ACTIVE TARGETING, 2025-2030 (USD MILLION)
TABLE 149. EUROPE, MIDDLE EAST & AFRICA NDDS IN CANCER THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 150. EUROPE, MIDDLE EAST & AFRICA NDDS IN CANCER THERAPY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 151. EUROPE, MIDDLE EAST & AFRICA NDDS IN CANCER THERAPY MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 152. EUROPE, MIDDLE EAST & AFRICA NDDS IN CANCER THERAPY MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 153. EUROPE, MIDDLE EAST & AFRICA NDDS IN CANCER THERAPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 154. EUROPE, MIDDLE EAST & AFRICA NDDS IN CANCER THERAPY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 155. EUROPE, MIDDLE EAST & AFRICA NDDS IN CANCER THERAPY MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 156. EUROPE, MIDDLE EAST & AFRICA NDDS IN CANCER THERAPY MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 157. EUROPE, MIDDLE EAST & AFRICA NDDS IN CANCER THERAPY MARKET SIZE, BY NANOTECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 158. EUROPE, MIDDLE EAST & AFRICA NDDS IN CANCER THERAPY MARKET SIZE, BY NANOTECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 159. EUROPE, MIDDLE EAST & AFRICA NDDS IN CANCER THERAPY MARKET SIZE, BY ACTIVE TARGETING, 2018-2024 (USD MILLION)
TABLE 160. EUROPE, MIDDLE EAST & AFRICA NDDS IN CANCER THERAPY MARKET SIZE, BY ACTIVE TARGETING, 2025-2030 (USD MILLION)
TABLE 161. EUROPE, MIDDLE EAST & AFRICA NDDS IN CANCER THERAPY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 162. EUROPE, MIDDLE EAST & AFRICA NDDS IN CANCER THERAPY MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 163. UNITED KINGDOM NDDS IN CANCER THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 164. UNITED KINGDOM NDDS IN CANCER THERAPY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 165. UNITED KINGDOM NDDS IN CANCER THERAPY MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 166. UNITED KINGDOM NDDS IN CANCER THERAPY MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 167. UNITED KINGDOM NDDS IN CANCER THERAPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 168. UNITED KINGDOM NDDS IN CANCER THERAPY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 169. UNITED KINGDOM NDDS IN CANCER THERAPY MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 170. UNITED KINGDOM NDDS IN CANCER THERAPY MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 171. UNITED KINGDOM NDDS IN CANCER THERAPY MARKET SIZE, BY NANOTECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 172. UNITED KINGDOM NDDS IN CANCER THERAPY MARKET SIZE, BY NANOTECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 173. UNITED KINGDOM NDDS IN CANCER THERAPY MARKET SIZE, BY ACTIVE TARGETING, 2018-2024 (USD MILLION)
TABLE 174. UNITED KINGDOM NDDS IN CANCER THERAPY MARKET SIZE, BY ACTIVE TARGETING, 2025-2030 (USD MILLION)
TABLE 175. GERMANY NDDS IN CANCER THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 176. GERMANY NDDS IN CANCER THERAPY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 177. GERMANY NDDS IN CANCER THERAPY MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 178. GERMANY NDDS IN CANCER THERAPY MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 179. GERMANY NDDS IN CANCER THERAPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 180. GERMANY NDDS IN CANCER THERAPY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 181. GERMANY NDDS IN CANCER THERAPY MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 182. GERMANY NDDS IN CANCER THERAPY MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 183. GERMANY NDDS IN CANCER THERAPY MARKET SIZE, BY NANOTECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 184. GERMANY NDDS IN CANCER THERAPY MARKET SIZE, BY NANOTECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 185. GERMANY NDDS IN CANCER THERAPY MARKET SIZE, BY ACTIVE TARGETING, 2018-2024 (USD MILLION)
TABLE 186. GERMANY NDDS IN CANCER THERAPY MARKET SIZE, BY ACTIVE TARGETING, 2025-2030 (USD MILLION)
TABLE 187. FRANCE NDDS IN CANCER THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 188. FRANCE NDDS IN CANCER THERAPY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 189. FRANCE NDDS IN CANCER THERAPY MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 190. FRANCE NDDS IN CANCER THERAPY MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 191. FRANCE NDDS IN CANCER THERAPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 192. FRANCE NDDS IN CANCER THERAPY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 193. FRANCE NDDS IN CANCER THERAPY MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 194. FRANCE NDDS IN CANCER THERAPY MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 195. FRANCE NDDS IN CANCER THERAPY MARKET SIZE, BY NANOTECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 196. FRANCE NDDS IN CANCER THERAPY MARKET SIZE, BY NANOTECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 197. FRANCE NDDS IN CANCER THERAPY MARKET SIZE, BY ACTIVE TARGETING, 2018-2024 (USD MILLION)
TABLE 198. FRANCE NDDS IN CANCER THERAPY MARKET SIZE, BY ACTIVE TARGETING, 2025-2030 (USD MILLION)
TABLE 199. RUSSIA NDDS IN CANCER THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 200. RUSSIA NDDS IN CANCER THERAPY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 201. RUSSIA NDDS IN CANCER THERAPY MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 202. RUSSIA NDDS IN CANCER THERAPY MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 203. RUSSIA NDDS IN CANCER THERAPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 204. RUSSIA NDDS IN CANCER THERAPY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 205. RUSSIA NDDS IN CANCER THERAPY MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 206. RUSSIA NDDS IN CANCER THERAPY MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 207. RUSSIA NDDS IN CANCER THERAPY MARKET SIZE, BY NANOTECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 208. RUSSIA NDDS IN CANCER THERAPY MARKET SIZE, BY NANOTECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 209. RUSSIA NDDS IN CANCER THERAPY MARKET SIZE, BY ACTIVE TARGETING, 2018-2024 (USD MILLION)
TABLE 210. RUSSIA NDDS IN CANCER THERAPY MARKET SIZE, BY ACTIVE TARGETING, 2025-2030 (USD MILLION)
TABLE 211. ITALY NDDS IN CANCER THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 212. ITALY NDDS IN CANCER THERAPY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 213. ITALY NDDS IN CANCER THERAPY MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 214. ITALY NDDS IN CANCER THERAPY MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 215. ITALY NDDS IN CANCER THERAPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 216. ITALY NDDS IN CANCER THERAPY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 217. ITALY NDDS IN CANCER THERAPY MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 218. ITALY NDDS IN CANCER THERAPY MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 219. ITALY NDDS IN CANCER THERAPY MARKET SIZE, BY NANOTECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 220. ITALY NDDS IN CANCER THERAPY MARKET SIZE, BY NANOTECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 221. ITALY NDDS IN CANCER THERAPY MARKET SIZE, BY ACTIVE TARGETING, 2018-2024 (USD MILLION)
TABLE 222. ITALY NDDS IN CANCER THERAPY MARKET SIZE, BY ACTIVE TARGETING, 2025-2030 (USD MILLION)
TABLE 223. SPAIN NDDS IN CANCER THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 224. SPAIN NDDS IN CANCER THERAPY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 225. SPAIN NDDS IN CANCER THERAPY MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 226. SPAIN NDDS IN CANCER THERAPY MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 227. SPAIN NDDS IN CANCER THERAPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 228. SPAIN NDDS IN CANCER THERAPY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 229. SPAIN NDDS IN CANCER THERAPY MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 230. SPAIN NDDS IN CANCER THERAPY MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 231. SPAIN NDDS IN CANCER THERAPY MARKET SIZE, BY NANOTECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 232. SPAIN NDDS IN CANCER THERAPY MARKET SIZE, BY NANOTECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 233. SPAIN NDDS IN CANCER THERAPY MARKET SIZE, BY ACTIVE TARGETING, 2018-2024 (USD MILLION)
TABLE 234. SPAIN NDDS IN CANCER THERAPY MARKET SIZE, BY ACTIVE TARGETING, 2025-2030 (USD MILLION)
TABLE 235. UNITED ARAB EMIRATES NDDS IN CANCER THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 236. UNITED ARAB EMIRATES NDDS IN CANCER THERAPY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 237. UNITED ARAB EMIRATES NDDS IN CANCER THERAPY MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 238. UNITED ARAB EMIRATES NDDS IN CANCER THERAPY MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 239. UNITED ARAB EMIRATES NDDS IN CANCER THERAPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 240. UNITED ARAB EMIRATES NDDS IN CANCER THERAPY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 241. UNITED ARAB EMIRATES NDDS IN CANCER THERAPY MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 242. UNITED ARAB EMIRATES NDDS IN CANCER THERAPY MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 243. UNITED ARAB EMIRATES NDDS IN CANCER THERAPY MARKET SIZE, BY NANOTECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 244. UNITED ARAB EMIRATES NDDS IN CANCER THERAPY MARKET SIZE, BY NANOTECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 245. UNITED ARAB EMIRATES NDDS IN CANCER THERAPY MARKET SIZE, BY ACTIVE TARGETING, 2018-2024 (USD MILLION)
TABLE 246. UNITED ARAB EMIRATES NDDS IN CANCER THERAPY MARKET SIZE, BY ACTIVE TARGETING, 2025-2030 (USD MILLION)
TABLE 247. SAUDI ARABIA NDDS IN CANCER THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 248. SAUDI ARABIA NDDS IN CANCER THERAPY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 249. SAUDI ARABIA NDDS IN CANCER THERAPY MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 250. SAUDI ARABIA NDDS IN CANCER THERAPY MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 251. SAUDI ARABIA NDDS IN CANCER THERAPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 252. SAUDI ARABIA NDDS IN CANCER THERAPY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 253. SAUDI ARABIA NDDS IN CANCER THERAPY MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 254. SAUDI ARABIA NDDS IN CANCER THERAPY MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 255. SAUDI ARABIA NDDS IN CANCER THERAPY MARKET SIZE, BY NANOTECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 256. SAUDI ARABIA NDDS IN CANCER THERAPY MARKET SIZE, BY NANOTECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 257. SAUDI ARABIA NDDS IN CANCER THERAPY MARKET SIZE, BY ACTIVE TARGETING, 2018-2024 (USD MILLION)
TABLE 258. SAUDI ARABIA NDDS IN CANCER THERAPY MARKET SIZE, BY ACTIVE TARGETING, 2025-2030 (USD MILLION)
TABLE 259. SOUTH AFRICA NDDS IN CANCER THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 260. SOUTH AFRICA NDDS IN CANCER THERAPY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 261. SOUTH AFRICA NDDS IN CANCER THERAPY MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 262. SOUTH AFRICA NDDS IN CANCER THERAPY MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 263. SOUTH AFRICA NDDS IN CANCER THERAPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 264. SOUTH AFRICA NDDS IN CANCER THERAPY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 265. SOUTH AFRICA NDDS IN CANCER THERAPY MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 266. SOUTH AFRICA NDDS IN CANCER THERAPY MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 267. SOUTH AFRICA NDDS IN CANCER THERAPY MARKET SIZE, BY NANOTECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 268. SOUTH AFRICA NDDS IN CANCER THERAPY MARKET SIZE, BY NANOTECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 269. SOUTH AFRICA NDDS IN CANCER THERAPY MARKET SIZE, BY ACTIVE TARGETING, 2018-2024 (USD MILLION)
TABLE 270. SOUTH AFRICA NDDS IN CANCER THERAPY MARKET SIZE, BY ACTIVE TARGETING, 2025-2030 (USD MILLION)
TABLE 271. DENMARK NDDS IN CANCER THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 272. DENMARK NDDS IN CANCER THERAPY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 273. DENMARK NDDS IN CANCER THERAPY MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 274. DENMARK NDDS IN CANCER THERAPY MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 275. DENMARK NDDS IN CANCER THERAPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 276. DENMARK NDDS IN CANCER THERAPY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 277. DENMARK NDDS IN CANCER THERAPY MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 278. DENMARK NDDS IN CANCER THERAPY MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 279. DENMARK NDDS IN CANCER THERAPY MARKET SIZE, BY NANOTECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 280. DENMARK NDDS IN CANCER THERAPY MARKET SIZE, BY NANOTECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 281. DENMARK NDDS IN CANCER THERAPY MARKET SIZE, BY ACTIVE TARGETING, 2018-2024 (USD MILLION)
TABLE 282. DENMARK NDDS IN CANCER THERAPY MARKET SIZE, BY ACTIVE TARGETING, 2025-2030 (USD MILLION)
TABLE 283. NETHERLANDS NDDS IN CANCER THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 284. NETHERLANDS NDDS IN CANCER THERAPY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 285. NETHERLANDS NDDS IN CANCER THERAPY MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 286. NETHERLANDS NDDS IN CANCER THERAPY MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 287. NETHERLANDS NDDS IN CANCER THERAPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 288. NETHERLANDS NDDS IN CANCER THERAPY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 289. NETHERLANDS NDDS IN CANCER THERAPY MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 290. NETHERLANDS NDDS IN CANCER THERAPY MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 291. NETHERLANDS NDDS IN CANCER THERAPY MARKET SIZE, BY NANOTECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 292. NETHERLANDS NDDS IN CANCER THERAPY MARKET SIZE, BY NANOTECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 293. NETHERLANDS NDDS IN CANCER THERAPY MARKET SIZE, BY ACTIVE TARGETING, 2018-2024 (USD MILLION)
TABLE 294. NETHERLANDS NDDS IN CANCER THERAPY MARKET SIZE, BY ACTIVE TARGETING, 2025-2030 (USD MILLION)
TABLE 295. QATAR NDDS IN CANCER THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 296. QATAR NDDS IN CANCER THERAPY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 297. QATAR NDDS IN CANCER THERAPY MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 298. QATAR NDDS IN CANCER THERAPY MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 299. QATAR NDDS IN CANCER THERAPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 300. QATAR NDDS IN CANCER THERAPY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 301. QATAR NDDS IN CANCER THERAPY MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 302. QATAR NDDS IN CANCER THERAPY MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 303. QATAR NDDS IN CANCER THERAPY MARKET SIZE, BY NANOTECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 304. QATAR NDDS IN CANCER THERAPY MARKET SIZE, BY NANOTECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 305. QATAR NDDS IN CANCER THERAPY MARKET SIZE, BY ACTIVE TARGETING, 2018-2024 (USD MILLION)
TABLE 306. QATAR NDDS IN CANCER THERAPY MARKET SIZE, BY ACTIVE TARGETING, 2025-2030 (USD MILLION)
TABLE 307. FINLAND NDDS IN CANCER THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 308. FINLAND NDDS IN CANCER THERAPY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 309. FINLAND NDDS IN CANCER THERAPY MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 310. FINLAND NDDS IN CANCER THERAPY MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 311. FINLAND NDDS IN CANCER THERAPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 312. FINLAND NDDS IN CANCER THERAPY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 313. FINLAND NDDS IN CANCER THERAPY MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 314. FINLAND NDDS IN CANCER THERAPY MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 315. FINLAND NDDS IN CANCER THERAPY MARKET SIZE, BY NANOTECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 316. FINLAND NDDS IN CANCER THERAPY MARKET SIZE, BY NANOTECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 317. FINLAND NDDS IN CANCER THERAPY MARKET SIZE, BY ACTIVE TARGETING, 2018-2024 (USD MILLION)
TABLE 318. FINLAND NDDS IN CANCER THERAPY MARKET SIZE, BY ACTIVE TARGETING, 2025-2030 (USD MILLION)
TABLE 319. SWEDEN NDDS IN CANCER THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 320. SWEDEN NDDS IN CANCER THERAPY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 321. SWEDEN NDDS IN CANCER THERAPY MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 322. SWEDEN NDDS IN CANCER THERAPY MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 323. SWEDEN NDDS IN CANCER THERAPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 324. SWEDEN NDDS IN CANCER THERAPY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 325. SWEDEN NDDS IN CANCER THERAPY MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 326. SWEDEN NDDS IN CANCER THERAP

Samples

Loading
LOADING...

Companies Mentioned

The major companies profiled in this NDDS in Cancer Therapy market report include:
  • Johnson & Johnson
  • F. Hoffmann-La Roche Ltd
  • Pfizer Inc.
  • Novartis AG
  • AstraZeneca PLC
  • Merck & Co., Inc.
  • Bristol-Myers Squibb Company
  • Sanofi S.A.
  • Amgen Inc.
  • AbbVie Inc.

Table Information

Report AttributeDetails
No. of Pages192
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 13.35 Billion
Forecasted Market Value ( USD ) by 2030 $ 24.98 Billion
Compound Annual Growth Rate13.3%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

NDDS in Cancer Therapy - Global Strategic Business Report - Product Image

NDDS in Cancer Therapy - Global Strategic Business Report

  • Report
  • 196 Pages
  • Global
From
Novel Drug Delivery Systems in Cancer Therapy - Global Strategic Business Report - Product Image

Novel Drug Delivery Systems in Cancer Therapy - Global Strategic Business Report

  • Report
  • 181 Pages
  • Global
From
Cancer Gene Therapy Market by Vector Type (Nonviral Vectors, Viral Vectors), Therapy Type (Ex Vivo, In Vivo), Indication, Stage, End User - Global Forecast 2025-2030 - Product Image

Cancer Gene Therapy Market by Vector Type (Nonviral Vectors, Viral Vectors), Therapy Type (Ex Vivo, In Vivo), Indication, Stage, End User - Global Forecast 2025-2030

  • Report
  • 182 Pages
  • Global
From
Immunotherapy Drugs Market by Therapy Type (Adoptive Cell Therapy, Cancer Vaccines, Checkpoint Inhibitors), Indication (Blood Cancer, Breast Cancer, Lung Cancer), Route Of Administration, End User, Mechanism Of Action - Global Forecast 2025-2030 - Product Image

Immunotherapy Drugs Market by Therapy Type (Adoptive Cell Therapy, Cancer Vaccines, Checkpoint Inhibitors), Indication (Blood Cancer, Breast Cancer, Lung Cancer), Route Of Administration, End User, Mechanism Of Action - Global Forecast 2025-2030

  • Report
  • 189 Pages
  • Global
From
Liver Cancer Drug Market Size, Share & Trends Analysis Report by Therapy (Targeted Therapy, Immunotherapy, Chemotherapy), Type (Hepatocellular Carcinoma), Distribution Channel (Hospital Pharmacies, Retail Pharmacies), Region, and Segment Forecasts 2025-2030 - Product Image

Liver Cancer Drug Market Size, Share & Trends Analysis Report by Therapy (Targeted Therapy, Immunotherapy, Chemotherapy), Type (Hepatocellular Carcinoma), Distribution Channel (Hospital Pharmacies, Retail Pharmacies), Region, and Segment Forecasts 2025-2030

  • Report
  • 100 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.